TEVA position history
The shares of Teva Pharmaceutical Industries (TEVA) that GLENVIEW CAPITAL MANAGEMENT, LLC reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2023 Q4: 1,604,633 shares, $17M, 0.36% of portfolio, New
- 2024 Q1: 7,501,284 shares, $106M, 1.9% of portfolio, Add +367.5%
- 2024 Q2: 9,157,641 shares, $149M, 2.9% of portfolio, Add +22.1%
- 2024 Q3: 8,456,324 shares, $152M, 2.9% of portfolio, Reduce −7.7%
- 2024 Q4: 8,456,324 shares, $186M, 4.7% of portfolio
- 2025 Q1: 14,778,641 shares, $227M, 5.6% of portfolio, Add +74.8%
- 2025 Q2: 15,824,223 shares, $265M, 7.4% of portfolio, Add +7.1%
- 2025 Q3: 16,692,680 shares, $337M, 7.5% of portfolio, Add +5.5%
- 2025 Q4: 16,720,209 shares, $522M, 10.6% of portfolio, Add +0.2%
- 2026 Q1: 6,660,220 shares, $201M, 5.0% of portfolio, Reduce −60.2%
- 2026 Q2: 5,081,091 shares, $172M, 3.1% of portfolio, Reduce −23.7%
- 2026 Q3: not held, Exit
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|